Treating head and neck cancer in the age of immunotherapy: a 2023 update
A Bhatia, B Burtness - Drugs, 2023 - Springer
Most patients diagnosed with head and neck squamous cell carcinoma (HNSCC) will
present with locally advanced disease, requiring multimodality therapy. While this approach …
present with locally advanced disease, requiring multimodality therapy. While this approach …
The role of human papillomavirus in nongenital cancers
DP Zandberg, R Bhargava, S Badin… - CA: a cancer journal …, 2013 - Wiley Online Library
Answer questions and earn CME/CNE Human papillomavirus (HPV), one of the most
common sexually transmitted diseases worldwide, has an established role in the …
common sexually transmitted diseases worldwide, has an established role in the …
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer
AA Forastiere, Q Zhang, RS Weber, MH Maor… - Journal of clinical …, 2013 - ascopubs.org
Purpose To report the long-term results of the Intergroup Radiation Therapy Oncology Group
91-11 study evaluating the contribution of chemotherapy added to radiation therapy (RT) for …
91-11 study evaluating the contribution of chemotherapy added to radiation therapy (RT) for …
Glioblastoma therapy using codelivery of cisplatin and glutathione peroxidase targeting siRNA from iron oxide nanoparticles
Y Zhang, X Fu, J Jia, T Wikerholmen, K Xi… - … applied materials & …, 2020 - ACS Publications
Glioblastoma (GBM) is the most common and lethal type of malignant brain tumor in adults.
Currently, interventions are lacking, the median overall survival of patients with GBM is less …
Currently, interventions are lacking, the median overall survival of patients with GBM is less …
Nanolongan with multiple on-demand conversions for ferroptosis–apoptosis combined anticancer therapy
As a type of programmed cell death, ferroptosis is distinct from apoptosis. The combination
of the two thus provides a promising modality with which to significantly improve anticancer …
of the two thus provides a promising modality with which to significantly improve anticancer …
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced …
L Zhong, C Zhang, G Ren, W Guo… - Journal of clinical …, 2013 - ascopubs.org
Purpose To evaluate induction chemotherapy with docetaxel, cisplatin, and fluorouracil
(TPF) followed by surgery and postoperative radiotherapy versus up-front surgery and …
(TPF) followed by surgery and postoperative radiotherapy versus up-front surgery and …
DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG
Platinum based drugs alone or in combination with 5FU and docetaxel are common regimen
chemotherapeutics for the treatment of advanced OSCC. Chemoresistance is one of the …
chemotherapeutics for the treatment of advanced OSCC. Chemoresistance is one of the …
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of …
P Blanchard, J Bourhis, B Lacas, MR Posner… - Journal of clinical …, 2013 - ascopubs.org
Purpose Cisplatin plus fluorouracil (PF) induction chemotherapy has been compared with
taxane (docetaxel or paclitaxel), cisplatin, and fluorouracil (Tax-PF) in randomized trials in …
taxane (docetaxel or paclitaxel), cisplatin, and fluorouracil (Tax-PF) in randomized trials in …
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis
C Petit, B Lacas, JP Pignon, QT Le, V Grégoire… - The Lancet …, 2021 - thelancet.com
Background Randomised, controlled trials and meta-analyses have shown the survival
benefit of concomitant chemoradiotherapy or hyperfractionated radiotherapy in the treatment …
benefit of concomitant chemoradiotherapy or hyperfractionated radiotherapy in the treatment …
Chemotherapy for oral cancer
L Hartner - Dental Clinics, 2018 - dental.theclinics.com
The past several years have seen major advances in the use of systemic therapy for
treatment of patients with oral cancer. Systemic therapy refers to chemotherapy and …
treatment of patients with oral cancer. Systemic therapy refers to chemotherapy and …